Among these, SSTR1 and SSTR2 were found to be consistently expressed in neuroendocrine neoplasms of the gastrointestinal/pancreatobiliary tract, and this discovery has led to revolutionary changes in the diagnosis and management of these tumours [4,5,6]. The gene discussed is SSTR2; the disease is neuroendocrine neoplasm.